The effectiveness of intravenous isoniazid and ethambutol in patients with tuberculosis meningoencephalitis
Journal Title: Туберкульоз, легеневі хвороби, ВІЛ-інфекція - Year 2018, Vol 0, Issue 2
Abstract
Objective — study the effectiveness of i/v administration of isoniazid and ethambutol in patients with tuberculosis meningoencephalitis (TM). Materials and methods. We observed 54 patients was located TM aged 20 to 60 years. The patients were divided into the 1st and 2nd groups. 23 patients with TM who received i/v chemotherapy with isoniazid and ethambutol were assigned to the 1st group. Rifampicin and pyrazinamide were used in the 1st group per os. The 2nd group included 31 patients with TM who received chemotherapy with isoniazid, ethambutol, rifampicin, and pyrazinamide per os. Results and discussion. Positive Xray dynamics of the chest was observed in 12 (52.1 %) patients in 1st group and 6 (19.3 %) in 2nd group (p < 0.05). Negative Xray dynamics was observed in 9 (39.1 %) patients in 1st group and 22 (70.9 %) — 2nd group (p < 0.05), no changes in 2 (8.7 %) of patients in 1st group and 3 (9,6 %) — 2nd group (p > 0.05) against the background of the corresponding clinical changes. In 1st group, 7 (30.4 %) patients died within the first two months, and 10 (32.2 %) in 2nd group (p > 0.05). Up to six months of treatment, another 2 (8.7 ± 6.0 %) patients with TM in 1st group and 12 (38.7 %) died in 2nd group (p < 0.05). Conclusions. Due to the i/v use of isoniazid and ethambutol in patients with TM, the main clinical manifestations of the disease were rapidly eliminated on the background of positive changes from the general analysis of blood and Xray dynamics in the lungs compared with the oral administration of antituberculosis drugs. Conducting this chemotherapy reduces mortality of patients compared with the control group. I/v use of isoniazid and ethambutol in patients with TM does not cause additional side effects compared with the control group.
Authors and Affiliations
D. O. Butov, M. M. Kuzhko, K. V. Yurko, N. O. Nekrasova, Т. V. Tlustova, T. S. Butova
Keywords
Related Articles
- EP ID EP298722
- DOI -
- Views 131
- Downloads 0
Extrapulmonary tuberculosis and miliary tuberculosis in patients with TB/HIV co-infection. Part 3
-
Correction of mexidol metabolic disorders in experimental pulmonary emphysema
Objective — to study the effectiveness of mexidol on the lipid peroxidation system/antioxidant protection in experimental pulmonary emphysema (PE). Materials and methods. The study is undertaken on 58 mature white rats w...
Features of relationships of patients and the doctor in the clinic of tuberculosis
With the scientific, technological and industrial potential of humanity on the rise, as well as advancement in the ability to improve the environment and significantly change its conditions of existence, the moral questi...
Predictors of development of HIV-associated neurological diseases
Objective — to study the impact of demographic, epidemiological and genetic factors on the course of HIV infection and manifestation of neurological diseases. Materials and methods. The study involved 70 patients with t...
Application of collapsotherapeutic methods in complex treatment of patients with disorder chemoresistant pulmonary tuberculosis
Objective — to determine the effectiveness of using collapsotherapeutic methods in the complex treatment of patients with destructive tuberculosis of the lungs. Materials and methods. The analysis of the results of trea...